Interferon-gamma Induces Reactive Oxygen Species and Endoplasmic Reticulum Stress at the Hepatic Apoptosis
Overview
Cell Biology
Affiliations
Interferon-gamma (IFN-gamma) induces cell-cycle arrest and p53-independent apoptosis in primary cultured hepatocytes. However, the detailed mechanism, including regulating molecules, is still unclear. In this study, we found that IFN-gamma induced generation of reactive oxygen species (ROS) in primary hepatocytes and that pyrrolidinedithiocarbamate (PDTC), an anti-oxidant reagent, completely suppressed IFN-gamma-induced hepatic apoptosis. PDTC blocked apoptosis downstream from IRF-1 and upstream from caspase activation, suggesting that the generation of ROS occurred between these stages. However, IFN-gamma also induced the generation of ROS in IRF-1-deficient hepatocytes, cells insensitive to IFN-gamma-induced apoptosis. Moreover, a general cyclooxygenase (COX) inhibitor, indomethacin (but not the cyclooxygenase 2-specific inhibitor, NS-398) also inhibited the apoptosis without blocking the generation of ROS. Both PDTC and indomethacin also blocked IFN-gamma-induced release of cytochrome c from mitochondria. These results suggest that ROS are not the only or sufficient mediators of IFN-gamma-induced hepatic apoptosis. In contrast, we also found that IFN-gamma induced endoplasmic reticulum (ER) stress proteins, CHOP/GADD153 and caspase 12, in wild-type primary hepatocytes, but induced only caspase 12 and not CHOP/GADD153 protein in IRF-1-deficient hepatocytes. These results suggest that IFN-gamma induces ER stress in primary hepatocytes. Both the ROS and ER stress induced by IFN-gamma may be complementary mediators that induce apoptosis in primary hepatocytes.
Hepatocytes and the art of killing Plasmodium softly.
Marques-da-Silva C, Schmidt-Silva C, Kurup S Trends Parasitol. 2024; 40(6):466-476.
PMID: 38714463 PMC: 11156546. DOI: 10.1016/j.pt.2024.04.004.
: How Tumor Cells Defend Against the Siege Weapons of Cytotoxic T Lymphocytes.
McKenzie B, Khazen R, Valitutti S Front Immunol. 2022; 13:894306.
PMID: 35592329 PMC: 9110820. DOI: 10.3389/fimmu.2022.894306.
Xiong H, Xi Y, Yuan Z, Wang B, Hu S, Fang C Oncoimmunology. 2022; 11(1):2044103.
PMID: 35273829 PMC: 8903773. DOI: 10.1080/2162402X.2022.2044103.
Hatton S, Pandey M Int J Mol Sci. 2022; 23(3).
PMID: 35163013 PMC: 8835271. DOI: 10.3390/ijms23031089.
Double-edged effects of interferons on the regulation of cancer-immunity cycle.
Zhang X, Wang S, Zhu Y, Zhang M, Zhao Y, Yan Z Oncoimmunology. 2021; 10(1):1929005.
PMID: 34262796 PMC: 8253121. DOI: 10.1080/2162402X.2021.1929005.